One other thing; although the FDA allowed over 300 people in the trial, there will be somewhere around 150 with half of that receiving the Nevro. Just in case I needed to feel even MORE blessed, right? I asked the rep when they thought this might become available in the US if the study goes well. He said that the company is being cautious and saying the second quarter of 2014, but he thinks it will be in the first quarter, perhaps February or March. That had been asked on here before, so I made a point to ask him that.